Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Timothy Charles Oldham B.Sc., BSc(Hons), L.L.B., LLB(Hons), Ph.D. | CEO, MD & Director | 386.66k | -- | -- |
| Mr. Angus Tester Ph.D. | Senior Director of Operations | -- | -- | -- |
| Ms. Janette Dixon | Head of Business Development | -- | -- | -- |
| Mr. Cameron Jones C.A. | Company Secretary | -- | -- | -- |
AdAlta Limited
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 9
Description
AdAlta Limited, a clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia. Its lead product is AD-214, which is in Phase II clinical trial for the treatment of fibrosis diseases, including idiopathic pulmonary fibrosis, eye fibrosis, and fibrosis diseases of the liver, skin and kidney, as well as for the treatment of age-related macular degeneration. AdAlta Limited has collaborative partnerships with GE Healthcare Technologies Inc to develop i-body enabled PET imaging agents for use in immuno-oncology; and Carina Biotech Pty Ltd to develop CAR-T cell therapies for solid tumor. The company was incorporated in 2006 and is based in Bundoora, Australia.
Corporate Governance
Upcoming Events
February 25, 2025 at 10:59 AM UTC - March 3, 2025 at 12:00 PM UTC
AdAlta Limited Earnings Date
Recent Events
Recent Events Information Not Available